 GlycoMimetics, Inc. Nasdaq: GLYC today announced that preclinical research on two of its drug candidates, uproleselan and GMI-1359, will be shared at the American Association for Cancer Research AACR Annual Meeting 2020, which will now be held virtually from June 22-24. 